Creoptix Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 31
Employees
  • Latest Deal Type
  • M&A

Creoptix General Information

Description

Developer of next-generation biosensors designed to accelerate discovery by providing cutting-edge tools for molecular interaction analysis. The company's biosensors focus on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research, enabling life science researchers to benefit from versatile carboxyl-coupling for a range of molecules and software, which integrates assay setup and data evaluation in one tool.

Contact Information

Website
www.creoptix.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Malvern Panalytical
Primary Office
  • Zugerstrasse 76
  • 8820 Wädenswil
  • Switzerland
+41 044 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Creoptix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 11-Jan-2022 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 30-Sep-2019 00.00 000.00 000.00 Completed Generating Revenue
2. Later Stage VC 22-Dec-2017 $558K $3.86M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 20-Nov-2013 $3.3M $3.3M Completed Generating Revenue
To view Creoptix’s complete valuation and funding history, request access »

Creoptix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000 000.00 000.00 00 000.00 0.000
Series C 00,000 000.00 000.00 00 000.00 00.000
Preferred A 000,000 000.00 000.00 00 000.00 00.000
Preferred Shares 00,000 000.00 000.00 00 000.00 0.000
Preferred Shares 4,338 $2.53 $2.53 1x $2.53 0.68%
Ordinary Shares 53,502 $22.73 $22.73 1x $22.73 8.35%
To view Creoptix’s complete cap table history, request access »

Creoptix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of next-generation biosensors designed to accelerate discovery by providing cutting-edge tools for molecular i
Discovery Tools (Healthcare)
Wädenswil, Switzerland
31 As of 2022
000.00
000000&0 000.00

00000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000000000000
Salt Lake City, UT
00 As of 0000
000.00
00000000000 000.00

0000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000000000 000000000 000 00000000000
Martinsried, Germany
00 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Creoptix Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carterra Venture Capital-Backed Salt Lake City, UT 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Martinsried, Germany 00 00.000 000000 - 000 00.000
0000000 Formerly VC-backed San Jose, CA 000 0000 000000&0 0000
You’re viewing 3 of 3 competitors. Get the full list »

Creoptix Patents

  • 16

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Creoptix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210241847-A1 Method for calculating kinetic parameters of a reaction network Pending 18-Jul-2018 00000000
EP-3824469-A1 Method for calculating kinetic parameters of a reaction network Pending 18-Jul-2018 00000000
EP-3706908-A1 Methods and assemblies for high throughput screening Pending 15-Dec-2017 000000000000
EP-3707518-A1 Assemblies and methods for screening sample fluids Pending 15-Dec-2017 000000000000
US-20210069707-A1 Assemblies and methods for screening sample fluids Pending 15-Dec-2017 B01L3/0293
To view Creoptix’s complete patent history, request access »

Creoptix Executive Team (5)

Name Title Board Seat Contact Info
Line Raquet Chief Executive Officer & Managing Director
Kaspar Cottier Ph.D Founder, Board Member & Chief Technology Officer
Cynzia Nardiello Head of Finance
Robert Schier Vice Chairman
You’re viewing 4 of 5 executive team members. Get the full list »

Creoptix Board Members (7)

Name Representing Role Since
Chris Radloff Self Chairman 000 0000
Jacqueline Ruedin Rüsch Privilege Ventures Board Member 000 0000
Jon Jörg Self Board Member 000 0000
Nicola Bramwell Creoptix Board Member 000 0000
Robert Schier Self Vice Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Creoptix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Creoptix Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aargauische Kantonalbank Corporation Minority 000 0000 000000 0
EuroUS Ventures Venture Capital Minority 000 0000 000000 0
Fongit Seed Invest Venture Capital Minority 000 0000 000000 0
Gebrüder Mende Family Office Minority 000 0000 000000 0
Privilege Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial